Wird geladen...

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

BACKGROUND: Riociguat is a soluble guanylate cyclase stimulator approved for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTPEH). The objective of this study was to evaluate right heart size and function assessed by echocardiography during long term treatm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respir Res
Hauptverfasser: Marra, Alberto M., Halank, Michael, Benjamin, Nicola, Bossone, Eduardo, Cittadini, Antonio, Eichstaedt, Christina A., Egenlauf, Benjamin, Harutyunova, Satenik, Fischer, Christine, Gall, Henning, Ghofrani, Hossein Ardeschir, Hoeper, Marius M., Lange, Tobias J., Olsson, Karen M., Klose, Hans, Grünig, Ekkehard
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2018
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6299931/
https://ncbi.nlm.nih.gov/pubmed/30567595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-018-0957-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!